FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Death Misclassifications in MAUDE Database

Researchers say they found substantial misclassification of patient deaths in the FDA MAUDE medical device database.

FDA General

FDA Working with CBP to Identify Illicit Vaping Products

FDA acting commissioner Ned Sharpless says the agency is working with Customs and Border Protection to identify potentially illicit vaping products co...

Medical Devices

Medtronic Breakthrough with Aortic Aneurysm Stent

FDA grants Medtronic a breakthrough device designation for its Valiant TAAA Stent Graft System for repairing thoracoabdominal aortic aneurysms.

Human Drugs

Octapharmas Wilate Expanded Use in Adults/Adolescents

FDA approves Octapharmas Wilate (von Willebrand factor/coagulation factor VIII complex) for treating adults and adolescents with hemophilia A for rout...

Human Drugs

FDA Denies Olmesartan Withdrawal Petition

FDA denies a Public Citizen petition seeking removal of products containing olmesartan medoxomil from the market for safety reasons.

Human Drugs

Clarus Wants FDA Testosterone-Ester Guidance

Clarus asks FDA for written guidance on safety and efficacy standards needed for approval of an application for oral testosterone-ester prodrugs.

Human Drugs

FDA Hits Troubled Aurobindo with Form-483

FDA issues Aurobindo a Form-483 after an inspection last month at the firms Unit 7 manufacturing facility in Telangana, India.

Human Drugs

Prices Increases Not Justified for 7 Drugs: ICER

The Institute for Clinical and Economic Review identifies nine drugs whose 2017-2018 price increases were not supported by evidence of additional clin...

Federal Register

New Info Collection on FDA Fellowship Programs

Federal Register notice: FDA submits to OMB a new information collection conflict of interest information for non-employee fellowship programs partici...

Medical Devices

6 FDA Software Exemption Guidances Analyzed

Akin Gump attorneys highlight provisions in a package of six guidances issued by FDA to clarify its position on software exemptions under the 21st Cen...